Evidence map›Paper›PMID 31065394›Full record

ArticleCase reports in oncological medicine2019

Small-Cell Type, Poorly Differentiated Neuroendocrine Carcinoma of the Gallbladder: A Case Report and Review of the Literature.

Kishore Kumar, Hassan Tariq, Rafeeq Ahmed, Chime Chukwunonso, Masooma Niazi, Ariyo Ihimoyan

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in oncological medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kishore KumarDepartment of Medicine, Bronxcare Health System, Bronx, New York, USA.ORCID 0000-0002-9768-5354
Hassan TariqDepartment of Medicine, Bronxcare Health System, Bronx, New York, USA.ORCID 0000-0002-9178-0342
Rafeeq AhmedDepartment of Medicine, Bronxcare Health System, Bronx, New York, USA.
Chime ChukwunonsoDepartment of Medicine, Bronxcare Health System, Bronx, New York, USA.ORCID 0000-0003-4160-0769
Masooma NiaziDepartment of Pathology, Bronxcare Health System, Bronx, New York, USA.
Ariyo IhimoyanDepartment of Medicine, Bronxcare Health System, Bronx, New York, USA.ORCID 0000-0003-0257-4983
Montefiore Health System · USMemorialCare Health System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The poorly differentiated small-cell type, neuroendocrine carcinoma (NEC) of the gallbladder is a very uncommon subtype of a neuroendocrine tumor of the gastrointestinal tract. Nonsecretory NEC by virtue of its nonspecific and subtle clinical presentation of the tumor is usually diagnosed at an advance stage with presenting symptoms related to either locally advance disease or from metastatic disease. Though the radiologic imaging does identify the gall bladder cancer, the tumor lacks a specific diagnostic test; therefore, the diagnosis is almost always confirmed on histopathologic and immunohistochemical staining. We present a case of a poorly differentiated, small-cell neuroendocrine tumor of the gallbladder. The patient died within 3 months after the definitive diagnosis was made. Survival from this deadly malignancy can be improved with aggressive surgical treatment followed by chemotherapy and radiotherapy on a case-by-case scenario. The systemic chemotherapy remained the treatment of choice for an unresectable tumor (Chen et al., 2014).

Identifiers

PMID31065394
PMCPMC6466883
OpenAlexW2932952337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.